PET-radioimmunodetection of integrins: imaging acute colitis using a ⁶⁴Cu-labeled anti-β₇ integrin antibody

Jason L J Dearling1, Alan B Packard

  • 1Division of Nuclear Medicine, Department of Radiology, Children's Hospital Boston, 300 Longwood Avenue, Boston, MA, USA. Jason.Dearling@childrens.harvard.edu

Insights

This study developed a method to image integrin beta-7 distribution in vivo using a radiolabeled antibody. This technique successfully visualized higher antibody uptake in the inflamed gut of mice with colitis, aiding disease monitoring.

Area of Science:

  • Molecular Imaging
  • Immunology
  • Gastroenterology

Background:

  • Integrins mediate crucial cell interactions, and their in vivo imaging is vital for understanding disease and therapy.
  • Integrin beta-7 (β(7)) is expressed on lymphocytes involved in gut inflammation.

Purpose of the Study:

  • To establish a protocol for noninvasive, high-resolution imaging of in vivo integrin β(7) distribution.
  • To assess the potential for clinical translation in monitoring inflammatory gut diseases and therapies.

Main Methods:

  • A whole antibody targeting integrin β(7) was purified and conjugated with a bifunctional chelator.
  • The antibody was radiolabeled with Copper-64 ((64)Cu), a positron-emitting radionuclide.
  • MicroPET imaging was performed in mice with DSS-induced colitis to assess in vivo distribution.

Main Results:

  • The (64)Cu-labeled antibody successfully imaged integrin β(7) distribution in vivo.
  • Significantly higher uptake of the radiolabeled antibody was observed in the inflamed gut of mice with colitis compared to controls.

Conclusions:

  • This radiolabeled antibody imaging protocol provides a viable method for visualizing integrin β(7) in inflammatory conditions.
  • The technique shows promise for noninvasive monitoring of gut inflammation and therapeutic responses in clinical settings.